The goal of this clinical trial is to learn if agenT-797 is safe to use on people undergoing allogenic hematological stem cell transplantation (SCT). The main …

Allogenic Stem Cell TransplantationMyeloid MalignanciesLymphoid Malignancies+3 more

~Estimated

~$10 – $6,250

University of Wisconsin, MadisonNCT07758218

Phase 1

An Open Label, Phase 1/2 Study Evaluating Immunomodulatory AVM0703 in Patients With Lymphoid Malignancies (OPAL Study)

This is an open-label, Phase 1/2 study designed to characterize the safety, tolerability, Pharmacokinetics(PK), and preliminary antitumor activity of AVM0703 a…

Lymphoid Malignancies

~Estimated

~$10 – $8,750

AVM Biotechnology IncNCT04329728

Phase 1

Feasibility Study of CD34 Selection for GVHD Prophylaxis Using the Automated CliniMACS

Patients with graft failure or delayed engraftment may benefit from a hematopoietic stem cell boost or an additional hematopoietic stem cell transplantation pr…

AMLALLLymphoid Malignancies+3 more

~Estimated

~$10 – $6,250

University of Alabama at BirminghamNCT06047886